Key result
mRNA vaccine-associated myocarditis linked to mitochondrial abnormalities and severe LVEF reductions to 10-30%.
Why the study?
Myocarditis has emerged as a rare but severe adverse effect of COVID-19 mRNA vaccines, predominantly affecting young males.
Does mRNA vaccination induce myocarditis and reduce cardiac function in subjects with mitochondrial vulnerability?
Case-Control (n=6)
No
Does mRNA vaccination induce myocarditis and reduce cardiac function in subjects with mitochondrial vulnerability?
Mitochondrial vulnerability increases the risk of mRNA vaccine-associated myocarditis via ROS-mediated necroptosis, which can be mitigated by estrogen receptor modulation or ROS scavenging.
Answers are grounded in this paper and cite their sources.
May warrant caution with mRNA vaccines in mitochondrial disease; hypothesis-generating and requires prospective trials before changing practice.
mRNA vaccines against SARS-CoV-2 have been widely adopted to combat the COVID-19 pandemic. However, myocarditis has emerged as a rare but severe adverse effect, predominantly affecting young males. Here, we show that mitochondrial vulnerability is associated with mRNA vaccine-associated myocarditis. In our case-control study, patients with postvaccination myocarditis exhibited mitochondrial abnormalities. To examine the impact of mitochondrial damage, mRNA vaccines were administered to Polg+/D257A mice, which heterozygously express a proofreading-deficient mitochondrial DNA polymerase that sensitizes mitochondria to stress. mRNA vaccination in Polg+/D257A mice reduced left ventricular ejection fraction and induced cardiac immune cell infiltration. Bazedoxifene, a selective estrogen receptor modulator, prevented the reduction of cardiac function in Polg+/D257A mice, suggesting a protective role for estrogen signaling. Notably, mRNA vaccination induced mitochondrial reactive oxygen species, resulting in RIPK3 activation, a necroptosis-related kinase, in cardiomyocytes. Collectively, we propose that mitochondrial vulnerability is a potential risk factor for myocarditis following mRNA vaccination, possibly through reactive oxygen species-mediated necroptosis signaling. This study shows that mitochondrial vulnerability increases the risk of myocarditis after mRNA vaccination by promoting inflammatory cell death in cardiomyocytes, identifying a potential mechanism underlying rare but severe cardiac adverse events.
No takes yet. Share an insight, caveat, or question.
Mori et al. (2026) conducted a case-control in mRNA vaccine-associated myocarditis (n=6). COVID-19 mRNA vaccine vs. Healthy controls and Löffler syndrome patient was evaluated on Mitochondrial abnormalities and cardiac function. Patients with mRNA vaccine-associated myocarditis exhibited mitochondrial abnormalities and reduced left ventricular ejection fractions, which dropped to 10-30% in severe cases.
Synapse has enriched 10 related papers. Consider them for comparative context: